“Anti-infective peptide LL37 sustained delivery system — a potential novel treatment method of ocular infections. Report 2. Antiviral properties of silica nanoparticle encapsulated LL37”, Ukr. j. ophthalmol. , no. 3, pp. 53–57, Jul. 2026, doi: 10.31288/oftalmolzh201435357.